Delaware
|
0-19879
|
11-3054851
|
(State
or Other Jurisdiction Of Incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification No.)
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
Exhibit
Number
|
Description
of Exhibit
|
2.1
|
Asset
Purchase Agreement, dated March 3, 2006, among BTC, ABC and DFB Biotech,
Inc.
(Portions
of the Asset Purchase Agreement have been omitted pursuant to a request
for confidential treatment.)
|
99.1
|
Press
Release
|
Date:
March 9, 2006
|
BIOSPECIFICS
TECHNOLOGIES CORP.
|
|
(Registrant)
|
||
/s/Thomas
Wegman
|
||
Thomas
Wegman
President
|